WNT signaling–lung cancer is no exception J Rapp, L Jaromi, K Kvell, G Miskei, JE Pongracz Respiratory research 18, 1-16, 2017 | 106 | 2017 |
ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling M Vesel, J Rapp, D Feller, E Kiss, L Jaromi, M Meggyes, G Miskei, B Duga, ... Respiratory research 18, 1-11, 2017 | 87 | 2017 |
Multiple suppression pathways of canonical Wnt signalling control thymic epithelial senescence Z Varecza, K Kvell, G Talabér, G Miskei, V Csongei, D Bartis, G Anderson, ... Mechanisms of Ageing and Development 132 (5), 249-256, 2011 | 46 | 2011 |
Toxicology studies of primycin-sulphate using a three-dimensional (3D) in vitro human liver aggregate model Á Pénzes, EMM Abdelwahab, J Rapp, ZA Péteri, J Bovári-Biri, C Fekete, ... Toxicology letters 281, 44-52, 2017 | 4 | 2017 |
Studies on Lung Lavage Alphai Proteinase Inhibitor GZ Miskei University of Birmingham, 1998 | | 1998 |